HEALTHSTAT NEWS
STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals
Lawmakers are urging the U.S. Department of Health and Human Services to force Eli Lilly to reinstate 340B drug discounts to hospitals. The company stopped offering discounts to 50 hospital systems that failed to comply with a new policy requiring claims data sharing. Lawmakers argue Lilly's actions violate federal law by eliminating mandated price breaks.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
- STAT+: Medicare takes another swing at 340B cuts to hospitals
- STAT+: Cassidy proposes bill to rein in 340B drug discount program
- A proposed Medicare reimbursement change could reshape hospital drug pricing
- STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more